February 12, 2024

Trends and Complications after the LACC Trial with Gabriella Schivardi

Listen Later

25 minutes

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Gabriella Schivardi to discuss trends and complications after the LACC Trial. Dr. Schivardi is a first year ESGO fellow at the European Institute of Oncology in Milan and a research collaborator at the Gynecologic Oncology Department at Mayo Clinic, Rochester, United States. In addition, she is a former fellow for the IJGC.

Highlights:

The study observed a significant decrease in the use of the minimally invasive approach after the publication of the LACC trial.

Within our population the 30-day major complication, minor complication, and unplanned hospital readmission rates remained stable between the pre- and post-LACC periods.

The study observed an increased rate accross the publication of the LACC trial limited to the intra and post-operative transfusion rate.

The lack of a rise in 30-day complication rates after the LACC trial publication supports the use of laparotomy as the standard of care.

...more

View all episodes

View all episodes

Download on the App Store

Download on the App Store

Get it on Google Play

IJGC Podcast

By BMJ Group

5

2323 ratings

February 12, 2024

Trends and Complications after the LACC Trial with Gabriella Schivardi

Listen Later

25 minutes

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Gabriella Schivardi to discuss trends and complications after the LACC Trial. Dr. Schivardi is a first year ESGO fellow at the European Institute of Oncology in Milan and a research collaborator at the Gynecologic Oncology Department at Mayo Clinic, Rochester, United States. In addition, she is a former fellow for the IJGC.

Highlights:

The study observed a significant decrease in the use of the minimally invasive approach after the publication of the LACC trial.

Within our population the 30-day major complication, minor complication, and unplanned hospital readmission rates remained stable between the pre- and post-LACC periods.

The study observed an increased rate accross the publication of the LACC trial limited to the intra and post-operative transfusion rate.

The lack of a rise in 30-day complication rates after the LACC trial publication supports the use of laparotomy as the standard of care.

...more